2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions): A Report of the ACC Competency Management Committee

TY - JOUR

T1 - 2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions)

T2 - A Report of the ACC Competency Management Committee

AU - Creager, Mark A.

AU - Hamburg, Naomi M.

AU - Calligaro, Keith D.

AU - Casanegra, Ana I.

AU - Freeman, Rosario

AU - Gordon, Phyllis A.

AU - Gornik, Heather L.

AU - Kim, Esther S.H.

AU - Leeper, Nicholas J.

AU - Merli, Geno J.

AU - Niazi, Khusrow

AU - Olin, Jeffrey W.

AU - Quiroz, Rene

AU - Rrapo Kaso, Elona

AU - Wasan, Suman

AU - Waxler, Andrew R.

AU - White, Christopher J.

AU - White Solaru, Khendi

AU - Williams, Marlene S.

N1 - Funding Information: The work of the writing committee was supported exclusively by the ACC without commercial support. Writing committee members volunteered their time to this effort. Conference calls of the writing committee were confidential and attended only by committee members. To avoid actual, potential, or perceived conflict of interest resulting from relationships with industry (RWI) or other entities held by writing committee members or peer reviewers of the document, individuals were required to disclose all current healthcare-related relationships, including those existing 12 months before initiation of the writing effort. The ACC Competency Management Committee reviewed these disclosures to identify products (currently marketed or under development) pertinent to the document topic. Based on this information, the writing committee was selected to ensure that the chair and a majority of members had no relevant RWI. RWI was reviewed at the start of all meetings and conference calls and updated as changes occurred. Relevant RWI for authors is disclosed in Appendix 1. To ensure transparency, comprehensive RWI for authors, including RWI not pertinent to this document, is posted in Supplemental Appendix I. Employment information and affiliations of the peer reviewers are shown in Appendix 2. There are no RWI restrictions for participation in peer review, in the interest of encouraging comments from a variety of constituencies to ensure that a broad range of viewpoints inform final document content. Reviewers are required, however, to disclose all healthcare-related RWI and other entities, and their disclosure information is posted in Supplemental Appendix II. Disclosure information for the ACC Competency Management Committee is available online as well as the ACC disclosure policy for document development.

PY - 2021/2/1

Y1 - 2021/2/1

KW - AHA Scientific Statements

KW - Raynaud phenomenon

KW - aortic diseases

KW - cerebrovascular disease

KW - clinical competence

KW - fellowship training

KW - lymphedema

KW - peripheral artery disease

KW - vascular medicine

KW - venous insufficiency

KW - venous thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=85102211795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85102211795&partnerID=8YFLogxK

U2 - 10.1161/HCV.0000000000000079

DO - 10.1161/HCV.0000000000000079

M3 - Review article

C2 - 33448231

AN - SCOPUS:85102211795

SN - 1941-7640

VL - 14

SP - E000079

JO - Circulation: Cardiovascular Interventions

JF - Circulation: Cardiovascular Interventions

IS - 2

ER -